Financing growth: Walking the tightrope InsightIn the context of the particularly difficult public markets we have seen recently, Hannah Kuchler, Global Pharmaceuticals Correspondent at the Financial Times, chaired a panel of experts exploring what sources of capital are currently available to fund innovation and the development of new drugs, and what is needed to access […]
We were proud to host a fantastic panel chaired by BioCentury’s European Editor Stephen Hansen with Soren Moller, Managing Partner of Novo Seeds; Karin Kleinhans, Partner of MRL Ventures Fund; Hakan Goker, Managing Director of M Ventures; Roel Bulthuis, Managing Partner at Inkef. This panel of Venture Capital (VC) investors discussed the strength of private […]
– World Class Speakers from Biotech & Healthcare Industry and Investment Community – Building the Future Industry ‘Champions’ LONDON, Sept. 30, 2021 /PRNewswire/ — Optimum Strategic Communications (Optimum), the International Strategic Healthcare Communications firm, will be hosting its 13th Annual Healthcare Investor Conference on Monday, 4 October 2021. Firmly established as a major thought leadership event in the European healthcare sector’s calendar, eminent […]
Optimum’s 11th Annual Healthcare Investor Conference 2019 at Bloomberg. Pop it in the diary now!
